BioCatalystWatch
ABOSWorkspace / ABOS / OverviewCompany library
Acumen Pharmaceuticals, Inc. logo

Acumen Pharmaceuticals, Inc.

Acumen Pharmaceuticals, Inc. (ABOS)

Website

Featured programme · ACU234

Price
Market cap
Next catalyst—
Cash

Chart & Events

Candle interval

Core Clinical

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Other pipelines

ACU301

Aβ oligomers × Transferrin receptor (TfR)

PreINDP1P2P3FilingApproved
ACU401

Aβ oligomers × Human transferrin receptor (hTfR)

PreINDP1P2P3FilingApproved
ACU234

Aβ oligomers

PreINDP1P2P3FilingApproved

History / paused

Toxic soluble Aβ oligomers

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

ABOS PR & News

PR & News

ABOS SEC archive